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ABSTRACT: Berberis asiatica Roxb. Ex. Dc., non Griff. Belongs to the family berberidaceae 
commonly occurring in the dry outer Himalaya, Assam etc. Roots along with stem bark s a 
reputed drug in Ayurvedic medicine contain several alkaloids. 50% Ethaolnic extract of roots 
reported to posses anti-cancer activity. The present study examines the antitumour effect of 
ethanolic root extract (BRE) against Dalton’s lymphoma ascites tumour cells and solid tumour 
in swiss albino mice, A significant enhancement of mean survival time of BRE treated tumour 
bearing mice was found. Oral administration of BRE reduced the solid tumour induced by DLE 
and restored the altered haematological parameters to normal. 
 
INTRODUCTION 
 
Berberis asiatica Roxb.ex DC., non Griff. 
(Family Berberidaceae) is a pretty ever 
green thorn shrub 1.8 to 2.4m in height with 
light brown rough bark and oblong-ovoid 
edible berries, commonly occurring on the 
dry outer Himalaya from 600 – 2550m from 
kumaon east wards and in Assam, Madhya 
Pradesh, Mount Abu also. (1,2) It is 
commonly known in vern acular. As 
Kilmora or kingora. 
 
Roots along with stem bark form a repute 
drug in Ayurvedic medicine. It contains 
several alkaloids viz. Berberine, Palmitine, 
Jatrorrhizine, Columbamine, Tetrahydra 
palmitine, berbamine, Oxyberberine and 
oxya canthine. (3,4,5) EtoH (50%) extract of 
roots re reported to possess spasmolytic and 
anticancer activity.(5,6). 
 
Fruits or berries are given as a mild laxative 
to children. Stems are recommended in 
rheumatism.  The root’s action is as 
powerful as quinine.  Decoction made from 
the root bring down fever.  The dried extract 
of the root known as “Rasault” or “Ras” is a 
highly esteemed drug in indigenous 
medicine.  It is bitter, tonic cholaguge used 
as a purgative for children as a blood –
purifier antipyretic antiseptic and for 
external application in conjunctivitis.  It has 
also been recommended for gastric and 
duodenal ulcers ad for haemorrhoids both 
localloy and internally (1,6,7).  In Unani 
system it is used in leprosy.  A yellow dye 
obtained from the roots and stems is of great 
value in tanning and for colouring leather. 
(8)   
 
MATERIALS AND METHODS 
Plants materials  
The fresh roots of B. asiatica Roxb. Ex. Dc., 
of 15-20 yrs old tree were collected from the 
village Manjoor 25 km away from Ooty, the 
Nilgiris, Tamil Nadu and identified at the 
Department of Pharmacognosy,  JSS 
College of Pharmacy, Ooty with the help of 
herbarium sheet. 
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Tumour cells 
 
Dalton’s lymphoma ascites tumor cells 
(DLA) was obtained from Amala cancer 
research centre, Amala Nagar, Trissur, 
Kerala. 
 
Chemicals 
 
All the chemicals used in the present stud 
were of analytical reagent quality. 
 
Animals 
 
Swiss albino mice weighing 17 to 25 gm 
supplied from our animal house, J.S.S 
College of pharmacy, Ooty, were housed in 
well ventilated cages and fed with normal 
mouse pellet feed (Lipton India) and water 
libitum were used for the study. 
 
Extraction and preparation of the test 
sample. 
 
The fresh samples of roots were collected, 
dried, ground and soaked in 50% aqueous 
ethnol for a week at room temperature (15-
25
oC) with occasional stirring. This 
procedure was repeated twice.  The pooled 
extracts were concentrated, evaporated to 
dryness under reduced pressure.  The yellow 
solid residue was stored at 4
oC in a closed 
container and designated as BRE (Berberis 
asiatica Root Extract) for our experiments.  
The extract was suspended in 1% gum 
acacia suitable dilutions were made and 
subjected to the various experimental 
studies. 
 
Effect of BRE on DLA tumour model  
 
Three groups (a,b,c) of animals were 
transplanted with one million cells of DLA 
intraperitoneally.  a,b,c group received BRE 
0.1mg, 0.2mg and 0.4 mg/g body weight 
respectively once / day orally for 10 days. 
According to the schedule of drug 
administration the mice from all the three 
groups were further divided into 4 groups 
(9,10,11). 
 
Groups 1 animals were treated 24 hours 
after tumour transplantation once daily for 
10 days. 
 
Group 2 animals were treated once daily 
form the eleventh day of tumour 
transplantation for 10 days. 
 
Group 3 animals were treated once daily for 
10 days prior to tumour transplantation. 
 
Group 4 animals were served as control 
treated with gum acacia (1%). 
 
All the mice were weighted on the day of 
tumour transplantation and at weekly 
intervals. Animal survival was monitered up 
to 40 days mean survival times (MST) were 
noted. Survival times of treated groups 
(1,2,3) were compared with those control 
group (4) and the % increase in life span 
(T/C%) was calculated (12,13) by the 
formula: 
 
% Increase in life span = T/C% 
 
          MST of treated group 
=   ___________________    x 100 
           MST of control group   
 
   
Effect of BRE on  Haematological 
Parameters 
 
In order to detect the influence of BRE on 
the hematological status of DLA bearing 
mice. The comparison was made amongst 
the above mentioned four groups of mice on 
the 14
th day after transplantation with 
normal mice  
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Blood was drawn from each mouse in the 
conventional way an white blood cells count 
(WBC), red blood cells count (RBC), 
differential count and haemoglobin (Hb) 
percentage were estimated. (15) 
 
Acute oral toxicity 
 
The dose response survival studies were 
performed after oral administration of the 
BRE in 1% gum acacia in graded doses, 
mortality was monitored for a period of 14 
days.  The LD 50 values were calculated 
(14) 
 
Effect of BRE on solid Tumour model     
 
Three groups (I,II,III) of animals were 
transplanted with one million cells each of 
DLA subcutaneously into the right hind limb 
for the solid tumour development.  Group I, 
II and III were received BRE o.1 mg and 0.4 
mg/g body weight one daily orally for 10 
days respectively.  The three groups of he 
animals were further subdivided into 4 
groups according to the schedule of drug 
administration and designation as group 
A,B,C and D (9,10,11) 
 
Group A animals were treated 24 hours after 
tumour transplantation once daily for 10 
days. 
 
Group B animals were treated once daily 
from the eleventh day of tumour 
transplantation for 10 days. 
 
Group D animals were served as control 
treated with gum acacia (1%). 
 
Solid tumours were measured form day 7
th, 
14
th , 21
st, 28
th of transplantation the volume 
was calculated using the formula V= /3π r1
2, 
r2
2. Where r1
2 & r2
2 are radii of tumours. 
(10). 
 
RESULTS 
Acute oral Toxity 
 
The LD50 for BRE was found to be 1738 
mg/kg body weight (Table No.1) At dose of 
500, 1000, 1500 mg/kg. no mortality was 
observed when the dose was increased the 
mortality was higher. At higher doses toxic 
systems like drowsiness, toxic systems like 
drowsiness, lethargy were observed.  The 
animals which could survive the lethal 
effects upto 3 days were able to survive and 
continue even upto 14 days. 
 
Survival time 
 
The effect of BRE on the survival of tumour 
bearing mice showed (Table No 2) the mean 
survival time for the control group to be 25 
days while it was 36 days (T/C % = 144) for 
the group treated for 10 days wit BRE (200 
mg/kg oral /day) 10 days after the tumour 
transplantation.  The MST of the group 
treated wit the higher dose (400 mg/kg 
oral/day) was formed to be 36 days only.   
The treated for 10 days sowed no 60 days 
survivors. 
 
Haematological Studies  
 
Haematological parameters (Table 4), of 
tumour bearing mice on day 14 were found 
to be significantly altered from the normal 
group.  The total WBC count was found to 
be increased In a differential count of WAC, 
the percent of neutrophils increased while 
the lymphocyte count decreased.  At the 
same time interval, BRE (400 mg/kg/day 
oral) treatment for 10 days a) after 24hrs 
tumour transplantation b) 10 days after 
tumour transplantation could restore those 
altered parameters near to normal. 
 
Solid Tumour 
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The effect of BRE on solid tumours is 
shown in Table 5.  Treatment with BRE 
reduced the solid tumour volume 
considerably.  The maximum solid tumour 
volume reduction was sown in treatment 
with 200 mg/kg body et/day/oral for 10 days 
24 hrs after tumour transplantation groups. 
 
For example tumour volume of untreated 
mice was 0.19 ml on7th day, 1.9 ml and on 
the 14
th day, 3.3 ml on the 28
th day while for 
t treated group the tumour volume was nil 
on the 7
th as well on the 14
th day, 0.7 ml on 
the 21
st day and 2.6 ml on the 28
th day.  The 
post treatment with 200 mg/ kg for 10 days 
24 hr after tumour transplantation sowed a 
considerable reduction in tumour volume. 
 
DISCUSSION AND CONCLUSION 
 
Anti – cancer activity of Berberis asiatica as 
been established (5,6). Present studies 
demonstrate the BRE is also effective 
against DLA which regressed after the 
treatment mean survival time of untreated 
tumour transplantation animals is about 25 
days with gradual increase in tumour 
volume till the death of the animals.  The 
volume of ascites fluid increases more 
rapidly in the ascites tumour during tumour 
growth.  Ascites fluid is the direct nutritional 
source to the tumour cells and the faster 
increase in ascites fluid with tumour growth 
(16). Treatment with BRE has shown the 
increase in the MST to 36 days and decrease 
in tumour volume which is comparable with 
average body weight change.  This 
significant enhancement of MST was found 
which was dose-dependent.  The antitumour 
effect of BRE was ore pronounced but failed 
to show any curative effect (no 60 day 
survivors) 
 
Analysis of the haematological parameters 
showed a minimum toxic effect in the mice 
which were cured by BRE treatment.  14 
days after tumour trans plantation, BRE 
treated groups were able to reverse the 
change in the haematological parameters. 
 
Effect of BRE on solid tumour reduction 
studies exhibited a significant tumour 
reducing property which was compared on 
28
th day wit normal. 
 
All these data point to the possibility of 
developing Berberies asciatica root extract 
as a novel potential agent in the area of 
cancer chemotherapy.  
 
Earlier reports indicated the presence of 
several alkaloids (5,6) further studies on the 
active principles of BRE to be carried out to 
confirm the anticancer activity. 
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Table No 1 
Acute Oral Toxicity 
 
Group 
 
Dose 
mg/kg 
 
Log 
Dose 
Dead/Total
 
 
% Dead Corrected  
 
Probit 
 
1 1500  3.18  0/10  0  2.5* 3.04 
2 1600  3.20  1/10  10 20  3.72 
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3 1700  3.23  4/10  40 40  4.75 
4 1800  3.26  7/10  70 70  5.25 
5 1900  3.28  9/10  90 90  6.28 
6 2000  3.30  10/10 100  97.5*  6.96 
N= number of animals (10 in each group) 
*Corrected%: 
For the 0% Mortality = 100 (0.25/n) 
 For the 100% Mortality = 100 (n-0.25/n) 
LD50 of the BRE: 178 mg/kg body weight 
 
Table No 2 
Effect of BRE on survival time 
 
Group & treatment   MST  % Increase in Life Span 
1 a  31.8 ± 1.2 ***  128 
   b  32.3 ± 1.4 ***  130 
   c  3.4 ± 1.4 ***  137 
2 a  33.7 ± 1.4 ***  135 
   b  35.5 ± 1.36 ***  143 
   c  35.8 ± 1.7***  144 
3 a  24.3 ± 0.8*  98 
   b  24.0 ± 0.6*  98 
   c  24.6 ± 1.22*  88 
4.1% Gum Acacia  2.8 ± 0.65   
 
a,b,c received 100, 200, 400 mg/kg body weight  
 
Group 1: Received the treatment 24 hrs after Tumour transplantation. 
Group 2: Received the treatment 11
th day after tumour transplantation. 
Group 3: Received the treatment 10 days prior to tumour transplantation.  
 
Values marked with *,**,*** indicated the significance (P<0.5, p<0.01, p<0.001, respectively). 
 
Values are mean ± S.E.M. of six animals in a group. 
 
Table No 3 
Effect of BRE on Body Weight 
 
Group & treatment   Body Weight  % Decrease in Body Wt 
1 a  4.7 ± 0.1 ***  31 
   b  3.3 ± 0.2 ***  52 
   c   3.35 ± 0.15 ***  52 
2 a   5.6 ± 0.21  **  19 
   b  4.7 ± 0.31 **  31 
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   c  4.7 ± 0.1***  31 
3 a   6.5 ± 0.3*  5 
   b   6.0 ± 0.2*  13 
   c   6.0± 0.3*  13 
4.1% Gum Acacia  6.9 ± 0.4    
a,b,c received 100, 200, 400 mg/kg body weight  
 
Group 1: Received the treatment 24 hrs after Tumour transplantation. 
Group 2: Received the treatment 11
th day after tumour transplantation. 
Group 3: Received the treatment 10 days prior to tumour transplantation.  
 
Values marked with *,**,*** indicated the significance (P<0.5, p<0.01, p<0.001, respectively). 
 
Values are mean ± S.E.M. of six animals in a group. 
 
Table No 4 
Effect of BRE on Haematological parameters  
 
Differential Count%  Group & 
treatment  
 
Total 
WBC 
cells 
/ml x 
106 
Total 
RBC 
cells 
/ml x 
106 
Hb (g%) 
  Lymphocyte Neutrophil Monocyte 
1 a  19.5 ± 
0.8*** 
8.7 ± 
2.1* 
14.3 ± 
0.2* 
43 ± 1.5***  53.5 ± 1.2***  3.2 ± 0.2* 
   b  17.3 ± 
1.4*** 
8.1 ± 
1.8* 
13.3 ± 
0.3* 
58.1 ± 
1.6*** 
40 ± 1.4 ***  2.1 ± 0.12* 
   c  16.0 ± 
0.3*** 
8.7 ± 
1* 
14.1 ±  
0.1* 
58 ± 1.3***  40.2 ± 6.8 ***  .3 ± 0.25* 
2 a  18.6 ± 
1.9 ** 
9.1 ± 
0.8* 
14.1 ± 
0.2* 
46 ± 1***  52.1 ± 1***  2.5 ± 0.2* 
   b  16.4 ± 
1.6 
*** 
8.5 ± 
0.7* 
14.3 ± 
0.3* 
56± 1.2***  43.3 ± 1.2***  3.1 ± 0.15* 
   c  16.0 ± 
1.3 
*** 
8.3 ± 
1.1* 
13.8 ± 
0.5* 
55 ± 1.9***  42.7 ±1.7***  3.4 ± 0.22* 
3 a  25.2 ± 
1.1 
*** 
9.4 ± 
05* 
14.1 ± 
0.4* 
35.1 ±2*  62.3 ± 1.6*  2.7 ±0.4* 
   b  24.3 ± 
1.9* 
8.3 ± 
1.2* 
13.8 ± 
0.35* 
37.4 ± 1.3*  61.4 ± 0.9*  2 ± 0.21* 
   c  24.3 ± 
1.2* 
8.7 ± 
1* 
13.9 ± 
0.32* 
37.3 ± 1.4*  61 ± 1.4*  2± 0.45* 
4.1% 
Gum 
25.3 ± 
0.9*** 
8.81 
±1* 
13.8 ± 
0.4* 
34 ± 1.1***  64.2 ± 1.7***  2.3 ± 0.4 
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Acacia 
Normal 12.7  ± 
1.4 
8.9 ± 
1 
13.6 ± 0.9  65.8 ± 1.4  33.1 ± 1.1   
 
a,b,c received 100, 200, 400 mg/kg body weight  
 
Group 1: Received the treatment 24 hrs after Tumour transplantation. 
Group 2: Received the treatment 10 day after Tumour transplantation. 
Group 3: Received the treatment 10 days prior to Tumour transplantation.  
 
Values marked with *,**,*** indicated the significance (P<0.5, p<0.01, p<0.001, respectively). 
 
Values are mean ± S.E.M. of six animals in a group. 
 
 
Table No 5 
Effect of BRE on Tumour Model 
 
Tumour Volume in Cubic Centimeter   Group & 
treatment  7
th Day  14
th  Day  21
st Day  28
th Day 
A  I  ----  ----  0.94  ± 0.09 ***  3.08 ± 0.29 *** 
    II   ----  ----  0.7  ± 0.8***  2.56 ± 0.165 *** 
    III  ----  ----  0.7  ± 0.8***  3.08 ± 0.12*** 
B  I  Not determined   1.5  ± 1.4 **  1.98 ± 0.073**    4.88 ± 0.16 *** 
    II   Not determined   1.46  ± 0.13 **  1.84 ± 0.04 **  4.42 ± 0.39*** 
    III  Not determined   1.52  ± 0.13 **  0.08 ± 2.02 **  4.46 ± 0.17 *** 
C  I  0.12  ± 0.01 ***  1.82  ± 0.22*  3.3 ± 0.24*  6.78 ± 0.21* 
    II   ----  1.8  ± 0.12*  3.2 ± 0.21*  6.2 ± 0.15* 
    III  ----  1.9  ± 0.12*  3.2 ± 0.19*  6.6 ± 0.25* 
D1% Gum 
Acacia  
0.19  ± 0.02  1.90  ± 0.29  3.30 ± 0.35  6.70 ± 0.26 
 
 
I,II,III received 100, 200, 400 mg/kg body weight  
 
Group A: Received the treatment 24 hrs after Tumour transplantation. 
Group B: Received the treatment 10 day after Tumour transplantation. 
Group C: Received the treatment 10 days prior to Tumour transplantation.  
 
Values are mean ± S.E.M. of six animals in a group. 
 
Group A, B, C were compared with D. 
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Values marked with *, **, *** indicated the significance (P<0.5, p<0.01, p<0.001, respectively). 
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